Inactive Instrument

Coland Holdings Limited

4144

KYG2379A1094

Coland Holdings Limited Announces the Appointment of Tsao Johua as Company's New Head of Company Secretary

March 18, 2020 at 05:52 am

Coland Holdings Limited announced the appointment of Tsao Johua, CFO of the Company as company's new head of Company Secretary, effective March 18.

Latest news about Coland Holdings Limited

Coland Holdings Limited Announces the Financial Supervisory Commission Approval of the Termination of the Its Public Company Status Since October 30, 2020	20-10-13	CI
Coland Holdings Limited Reports Impairment of Assets for the Second Quarter of 2020	20-08-13	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Oceanic World Sub Corp entered into Letter of Intent to acquire Coland Holdings Limited for TWD 2 billion.	20-07-26	CI
Coland Holdings Limited Announces Cash Dividend	20-07-22	CI
Golden Hexagon Investments Limited made a tender offer to acquire an additional 15% stake in Coland Holdings Limited for approximately TWD 310 million.	20-06-10	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-11	CI
Coland Holdings Limited Announces the Appointment of Tsao Johua as Company's New Head of Company Secretary	20-03-18	CI
Coland Holdings Limited Proposes Dividend Distribution	20-03-18	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-17	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Coland Holdings Limited Approves Distribution for 2018	19-05-30	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-12	CI
Coland Holdings Limited Proposes Dividend	19-02-25	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-24	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Reports Impairment Charges for the Third Quarter of 2018	18-11-13	CI
Coland Holdings Limited announced that it expects to receive TWD 405 million in funding	18-08-19	CI
Coland Holdings Limited Approves Distribution for 2017	18-06-15	CI
Coland Holdings Seeks Acquisitions	18-04-27	CI
Coland Holdings Limited announced that it expects to receive TWD 250 million in funding	18-04-26	CI
An unknown buyer cancelled the acquisition of Revlis Biotech Co., Ltd. from Coland Holdings Limited.	18-03-23	CI
An unknown buyer cancelled the acquisition of CDIB Healthcare Fund Ltd. from Coland Holdings Limited.	18-03-23	CI
The transaction has been cancelled as per closing tool guideline.	18-03-23	CI
Coland Holdings Limited Reports Earnings Results for the Month of February 2018, Fourth Quarter of 2017 and Full Year 2017	18-03-23	CI

Coland Holdings Limited is a Taiwan-based company principally engaged in the development and distribution of pharmaceuticals. The Company provides products for the treatment of hepatitis, respiratory system diseases, urinary systems, cardiovascular and nervous system diseases. The Company also offers medical equipment, spinal instrumentations and antibiotics. Its products include Adefovir Dipivoxil Tablets, Mycophenolate Mofetil Dispersible Tablets, Tiotropium Bromide Powder For Inhalation, Amoxicillin Sodium and Clavulanate Potassium for Injection and Lamivudine Tablets. The Company operates its businesses primarily in Mainland China.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
OTSUKA HOLDINGS CO., LTD.	+20.08%	22.46B
SANDOZ GROUP AG	+18.55%	15.04B
CIPLA LIMITED	+18.94%	13.98B
ZYDUS LIFESCIENCES LIMITED	+56.80%	13.15B
ONO PHARMACEUTICAL CO., LTD.	-10.55%	6.89B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.03%	5.71B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT.	+6.11%	4.69B

Generic Pharmaceuticals